Gastrolyzer Range joins Selig De Colombia Portfolio Expanding Access to Cutting-Edge HMBT Technology

MAIDSTONE, U.K. - Feb. 18, 2025 - PRLog -- Bedfont^® Scientific Limited, word leaders in breath analysis with over 48 years of knowledge and expertise in designing and manufacturing innovative medical breath analysis devices, are thrilled to have joined forces with Selig De Colombia. Specialising in nuclear medicine, medical devices and disinfection technologies, Selig De Colombia successfully completed registration for the Gastrolyzer^® range of hydrogen and methane breath test (HMBT) devices in November 2024.

The Gastrolyzer^® HMBT devices aid in the diagnosis of various gastrointestinal (GI) disorders, such as small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption. Hydrogen and Methane are gases produced when undigested carbohydrates are fermented in the gut; high levels of these gases can indicate potential GI disorders.

Jason Smith, CEO at Bedfont^®, comments, "We are thrilled with the registration of the Gastrolyzer^® range. The partnership with Selig De Colombia represents a significant milestone in our commitment to delivering innovative, high-quality solutions to the healthcare industry worldwide. Collaborating with a trusted leader like Selig De Colombia ultimately improves patient outcomes in Colombia."

With its strong commitment to providing healthcare professionals with the highest-quality technology and customer service, Selig De Colombia aligns perfectly with Bedfont's core values, making it a perfect choice for becoming a distributor in the Colombia region.

With the first shipment delivered in January, the partnership advances Bedfont's vision of a world where everyone can access instant, non-invasive, simple breath testing to aid medical diagnosis. To find out more about HBMT testing with the Gastrolyzer^® range, read our latest article, 'Importance of Quality Control in Hydrogen Methane Breath Testing' by Dr Jafar Jafari, director of GI Cognition and Head of Upper GI Physiology at the Guys and St Thomas' Hospital.

For more information on Bedfont^® breath analysis devices, please visit our website by clicking here (http://www.bedfont.com/).